跳至主要内容
临床试验/ACTRN12618000713291
ACTRN12618000713291招募中3 期

Efficacy and safety of local anesthesia in patients with head and neck tumors undergoing percutaneous endoscopic gastrostomy (PEG): Lidocaine versus ropivacaine - Prospective, randomized, double blind study

Instituto Português de Oncologia de Lisboa de Francisco Gentil, EPE0 个研究点目标入组 30 人开始时间: 2018年5月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients with head and neck tumors referedfor PEG placement without systemic analgesic therapy prior to PEG placement
  • Age 18 years old or older
  • Ability to provide informed consent

排除标准

  • Refusal of the patient
  • Inability to provide informed consent
  • Use of systemic analgesics prior to PEG placement
  • Contraindications for PEG placement (patients unable to take PEG, chronic liver disease, presence of ascites, thrombocytopenia (<50,000 platelets), coagulopathy (INR> 1.5).
  • Allergy to lidocaine, ropivacaine, paracetamol, metamizole magnesium or any of its components and excipients

研究者

发起方
Instituto Português de Oncologia de Lisboa de Francisco Gentil, EPE

相似试验